Related Experiment Video

Updated: Jun 8, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Concise guidance: diagnosis and management of giant cell arteritis

Bhaskar Dasgupta1,

  • 1Essex University Southend University Hospital, Westcliff-on-Sea, Essex. bhaskar.dasgupta@southend.nhs.uk

Clinical Medicine (London, England)
|September 21, 2010
PubMed

Insights

Giant cell arteritis (GCA), a common vasculitis, requires urgent treatment to prevent vision loss. Prompt diagnosis and management are crucial for patients with GCA and polymyalgia rheumatica (PMR).

Area of Science:

  • Rheumatology
  • Vasculitis
  • Internal Medicine

Background:

  • Giant cell arteritis (GCA), also known as temporal arteritis (TA), is a common vasculitis often associated with polymyalgia rheumatica (PMR).
  • GCA is a leading cause of long-term steroid use and a medical emergency due to the risk of critical ischemia.
  • Visual loss affects up to 20% of patients, highlighting the need for rapid diagnosis and intervention.

Purpose of the Study:

  • To emphasize the British Society for Rheumatology (BSR) and British Health Professionals in Rheumatology (BHPR) guidelines for PMR management.
  • To encourage prompt diagnosis and urgent management of GCA, focusing on preventing irreversible vision loss.
  • To provide a framework for GCA assessment, immediate treatment, and specialist referral for ongoing care.

Main Methods:

  • Review and summarization of recent BSR/BHPR guidelines on PMR management.
  • Emphasis on critical aspects of GCA diagnosis and immediate treatment protocols.
  • Outline of a referral pathway for specialist management, monitoring, and relapse prevention.

Main Results:

  • GCA requires immediate recognition and treatment as a medical emergency to avert ischemic complications, particularly visual loss.
  • Adherence to established guidelines ensures comprehensive disease assessment, timely intervention, and effective long-term monitoring.
  • A structured approach to GCA management can significantly reduce the incidence of preventable visual impairment.

Conclusions:

  • Prompt diagnosis and urgent management of GCA are paramount to prevent severe complications like blindness.
  • The provided guidance serves as a critical resource for healthcare professionals managing GCA and PMR patients.
  • Effective GCA treatment strategies, guided by expert recommendations, are essential for improving patient outcomes and preventing disability.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...